The 𝗡𝗼𝗻-𝗔𝗻𝗶𝗺𝗮𝗹 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 (𝗡𝗔𝗧) is a collaborative research community established by the NSW Government in 2024 to accelerate the development, validation, and adoption of innovative non-animal technologies (NATs) and new approach methodologies (NAMs) in health and medical research.
Backed by a $4.5 million investment, NAT-Net brings together eight leading research institutions across NSW, including University of New South Wales, University of Sydney, Children's Medical Research Institute, University of Technology Sydney, University of Newcastle, University of Wollongong, Hunter Medical Research Institute, and the Victor Chang Cardiac Research Institute. Administered by UNSW and funded by NSW Health,
NAT-Net is structured around three strategic pillars: 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: Supporting bold, collaborative projects through the NAT-Net Research Pillar Competitive Grant Scheme. 𝗜𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲: Improve integration of outputs into a coordinated NAT pipeline. 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆: Working with national and international regulators to promote the acceptance of NAT in research and clinical development.
NAT-Net champions technologies that offer more human-relevant, ethical, and effective alternatives to traditional animal-based models. These include organoids, organs-on-chips, AI-driven in silico modelling, and in chemico assays.
Through funding, partnerships, and thought leadership, NAT-Net is growing a connected, future-focused community across disciplines to overcome fragmentation, strengthen local capability, and position NSW as a global leader in non-animal research innovation.
Follow this page to receive updates on our events.